Abstract
Angiogenesis is a complex process of critical importance during development and in physiological and pathophysiological conditions. There is considerable research interest in studying the angiogenesis cascade and consequently a need for a physiologically valid, quantitative, and cost-effective assay. In this chapter, we describe the stem cell spheroid-based sprout assay in three-dimensional fibrin scaffold which allows fast and easy screening of pro- and anti-angiogenic effects of substances with a high degree of reproducibility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Folkman J, Klagsbrun M (1978) Angiogenic factors. Science 235:442–447
Auerbach R, Lewis R, Shinners BL et al (2003) Angiogenesis assay: a critical review. Clin Chem 49:32–40
Blacher S, Erpicum C, Lenoir B et al (2014) Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour. Plos One 9:e97019
Sleeman JP (2010) Understanding the mechanisms of lymphangiogenesis: a hope for cancer therapy? Phlebolymphology 17:99–107
Breier G (2000) Angiogenesis in embryonic development: a review. Placenta 21:S11–S15
Reynolds LP, Grazul-Bilska AT, Redmer DA (2002) Angiogenesis in the female reproductive organs: pathological implications. Int J Exp Pathol 83:151–163
Sinno H, Prakash S (2013) Complements and the wound healing cascade: an updated review. Plast Surg Int. doi:10.1155/2013/146764
Portal-Nunez S, Lozano D, Esbrit P (2012) Role of angiogenesis on bone formation. Histol Histopathol 27:559–566
Auerbach R, Akhtar N, Lewis RL et al (2000) Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev 19:167–172
Weis AM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359–1370
Sharifpanah F, Saliu F, Bekhite M et al (2014).β-Adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signaling. Cell Tissue Res 358:443–452
Maruotti N, Annese T, Cantatore FP et al (2013) Macrophages and angiogenesis in rheumatic diseases. Vasc Cell 5:11–18
Maruotti N, Cantatore FP, Crivellato E et al (2006) Angiogenesis in rheumatoid arthiritis. Histol Histopathol 21:557–566
Crawford TN, Alfaro DV, Kerrison JB et al (2009) Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 5:8–13
Guerard S, Pouliot R (2012) The role of angiogenesis in the pathogenesis of psoriasis: mechanisms and clinical implications. J Clin Exp Dermatol Res S2:007. doi:10.4172/2155-9554.S2-007
Kaminsky SM, Rosengart TK, Rosenberg J et al (2013) Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease. Hum Gene Ther 24:948–963
Norrby K (2006) In vivo models of angiogenesis. J Cell Mol Med 10:588–612
Nakatsu MN, Hughes CC (2008) An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol 443:65–82
Nehls V, Drenckhahn D (1995) A novel microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 50:311–322
Staton CA, Reed MWR, Brown NJ (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 90:195–221
Staton CA, Stribbling SM, Tazzyman S et al (2004) Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85:233–248
Koh W, Straman AN, Sacharidou A et al (2008) In vitro three-dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol 443:83–101
Zeitlin BD, Dong Z, Nör JE (2012) RAIN-Droplet: a novel 3D in vitro angiogenesis model. Lab Invest 92:988–998
Goodwin AM (2007) In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res 74:172–183
Wobus AM (2001) Potential of embryonic stem cells. Mol Aspects Med 22:149–164
Graf U, Casanova EA, Cinelli P (2011) The role of the leukemia inhibitory factor-pathway in derivation and maintenance of murine pluripotent stem cells. Genes 2:280–297
Wartenberg M, Günther J, Hscheler J et al (1998) The embryoid body as a novel in vitro assay system for anti-angiogenic agents. Lab Invest 78:1301–1314
Li J, Stuhlmann H (2011) In vitro imaging of angiogenesis using embryonic stem cell-derived endothelial cells. Stem Cells Dev 21:331–342
Shinkaruk S, Bayle M, Lain G et al (2003) Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr Med Chem Anticancer Agents 3:95–117
Dalton HJ, Armaiz-Pena GN, Gonzalez-Villasana V et al (2014) Monocytes subpopulations in angiogenesis. Cancer Res 74:1287–1293
Lingen MW (2001) Role of leukosytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 125:67–71
Walter J, Sane DC (2000) The role of smooth muscle cells and pericytes in angiogenesis. In: Mousa SA (ed) Angiogenesis inhibitors and stimulators: potential therapeutic implications. Landes Bioscience, Georgetown, Texas, pp 25–30. ISBN 13: 978-158706022933
Sharifpanah F, De Silva S, Bekhite M et al (2015) Stimulation of vasculogenesis and leukopoiesis of embryonic stem cells by extracellular transfer RNA and ribosomal RNA. Free Radic Biol Med 89:1203–1217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Sharifpanah, F., Sauer, H. (2016). Stem Cell Spheroid-Based Sprout Assay in Three-Dimensional Fibrin Scaffold: A Novel In Vitro Model for the Study of Angiogenesis. In: Martin, S., Hewett, P. (eds) Angiogenesis Protocols. Methods in Molecular Biology, vol 1430. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3628-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3628-1_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3626-7
Online ISBN: 978-1-4939-3628-1
eBook Packages: Springer Protocols